Full Breakdown
New Alzheimer’s Therapy Gives One Family a Prolonged Pause in Decline
7/17/2026, 9:31:04 PM
Early Detection and Emerging Therapies
Natalie Bryan, 49, moved her family back to Oklahoma City in 2021 after her father, James Nelson, began showing memory lapses in 2024. Prompt testing confirmed mild cognitive impairment due to Alzheimer’s disease, allowing him to start treatment while still in the early stage. He received bi-weekly infusions of Leqembi for 18 months and has now reduced to monthly doses. According to Dr. Anna Chodos, executive director of Dementia Care Aware, patients who begin disease-modifying drugs early can experience a markedly slower progression, though most still eventually regress.
Caregiver Landscape
The 2025 Caregiving in the U.S. report from AARP and the National Alliance for Caregiving notes that 27 % of the nation’s 63 million caregivers support someone with Alzheimer’s, dementia, or a related memory impairment. Many caregivers, like Bryan, worry that a diagnosis will add overwhelming responsibilities. Bryan says the treatment has lessened that burden, allowing her father to continue driving, assisting with her children, and participating in community activities such as Seniors Helping Seniors and church.
Official Perspectives
Dr. Chodos emphasizes that the primary aim of these disease-modifying agents is to keep patients in the earliest stages with minimal active disease progression, hoping to “freeze time” and possibly improve ancillary factors such as exercise, diet, and sleep. She also stresses the importance of connecting caregivers to community resources, noting that most patients are still diagnosed too late to qualify for these therapies.
Verbatim Quotes
- “I would say that we were hopeful, but we weren't expecting the results that we received,” — Natalie Bryan, caregiver
- “Everyone else, like, with my grandmother and friends' parents, 18 months, you can see a significant decline,” — Natalie Bryan
- “You also have to think about the physical care and the time that you want to spend with them," she said.” — Natalie Bryan
- “I expected I would have all these doctor's appointments and go with him, but he just takes himself,” — Natalie Bryan
These statements illustrate how early intervention with Leqembi can alter the trajectory of Alzheimer’s for both patients and their families, while underscoring the ongoing need for broader access and caregiver support.
